Arteris, Inc. (NASDAQ:AIP – Get Free Report) CEO K Charles Janac sold 73,894 shares of the company’s stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $30.00, for a total transaction of $2,216,820.00. Following the sale, the chief executive officer owned 8,355,177 shares of the company’s stock, valued at approximately $250,655,310. The trade was a 0.88% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
K Charles Janac also recently made the following trade(s):
- On Tuesday, August 4th, K Charles Janac sold 26,106 shares of Arteris stock. The stock was sold at an average price of $31.97, for a total value of $834,608.82.
- On Monday, July 6th, K Charles Janac sold 125,976 shares of Arteris stock. The shares were sold at an average price of $35.79, for a total value of $4,508,681.04.
- On Monday, July 6th, K Charles Janac sold 10,679 shares of Arteris stock. The shares were sold at an average price of $35.90, for a total value of $383,376.10.
- On Thursday, July 2nd, K Charles Janac sold 192,686 shares of Arteris stock. The stock was sold at an average price of $36.32, for a total value of $6,998,355.52.
- On Thursday, July 2nd, K Charles Janac sold 10,902 shares of Arteris stock. The stock was sold at an average price of $38.78, for a total value of $422,779.56.
- On Monday, June 8th, K Charles Janac sold 70,000 shares of Arteris stock. The shares were sold at an average price of $34.91, for a total value of $2,443,700.00.
- On Friday, May 8th, K Charles Janac sold 70,000 shares of Arteris stock. The shares were sold at an average price of $31.20, for a total value of $2,184,000.00.
Arteris Price Performance
AIP stock opened at $29.78 on Friday. The stock has a market capitalization of $1.37 billion, a price-to-earnings ratio of -34.23 and a beta of 1.96. The firm’s 50-day moving average price is $35.94 and its two-hundred day moving average price is $26.19. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.17. Arteris, Inc. has a 12-month low of $8.42 and a 12-month high of $50.26.
More Arteris News
Here are the key news stories impacting Arteris this week:
- Positive Sentiment: Jefferies upgraded Arteris from Hold to Buy and assigned a $50 price target, indicating substantial potential upside. Jefferies upgrade
- Positive Sentiment: Rosenblatt Securities reaffirmed its Buy rating and raised or maintained a $38 price target, while Roth Capital also initiated coverage with a Buy rating and a $40 target. The endorsements strengthen the bullish analyst backdrop for AIP. Rosenblatt rating Roth Capital rating
- Positive Sentiment: Arteris projected third-quarter revenue of $24 million to $25 million and updated full-year 2026 revenue guidance to $95 million to $98 million. Both ranges exceed consensus estimates of approximately $23.5 million and $94.2 million, respectively. Arteris results and guidance
- Neutral Sentiment: The company appointed Saurabh Sinha as chief financial officer and chief accounting officer, effective September 8, 2026. The leadership change may improve financial oversight, but investors may initially monitor the transition. CFO appointment
- Negative Sentiment: Second-quarter adjusted results showed a loss of $0.10 per share, worse than the expected loss of roughly $0.04-$0.05. Revenue of $24.13 million exceeded estimates, but the larger-than-expected loss likely drove selling pressure. Arteris second-quarter results
- Negative Sentiment: Recent filings disclosed sales by CEO K. Charles Janac, director Saiyed Atiq Raza, major shareholder Bayview Legacy and Vice President Paul Alpern. The concentration of insider selling may weigh on sentiment, although insiders retain significant positions.
Wall Street Analyst Weigh In
A number of equities analysts recently commented on the company. Oppenheimer assumed coverage on Arteris in a report on Thursday, July 16th. They set an “outperform” rating and a $40.00 target price for the company. Northland Securities set a $38.00 price objective on shares of Arteris in a research report on Wednesday, May 13th. Rosenblatt Securities restated a “buy” rating and issued a $38.00 price objective on shares of Arteris in a report on Friday. Weiss Ratings cut shares of Arteris from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, May 13th. Finally, Jefferies Financial Group raised shares of Arteris from a “hold” rating to a “buy” rating and set a $50.00 target price on the stock in a research note on Friday. Five research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Arteris has an average rating of “Moderate Buy” and a consensus price target of $41.00.
Get Our Latest Stock Report on AIP
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently made changes to their positions in AIP. Raymond James Financial Inc. bought a new stake in shares of Arteris during the second quarter valued at approximately $32,000. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in Arteris in the second quarter worth $53,000. Versant Capital Management Inc raised its holdings in Arteris by 33.7% in the second quarter. Versant Capital Management Inc now owns 1,150 shares of the company’s stock worth $56,000 after purchasing an additional 290 shares in the last quarter. BNP Paribas Financial Markets raised its holdings in Arteris by 75.0% in the third quarter. BNP Paribas Financial Markets now owns 6,053 shares of the company’s stock worth $61,000 after purchasing an additional 2,595 shares in the last quarter. Finally, Royal Bank of Canada lifted its position in Arteris by 366.7% during the first quarter. Royal Bank of Canada now owns 4,023 shares of the company’s stock valued at $66,000 after buying an additional 3,161 shares during the period. Hedge funds and other institutional investors own 64.36% of the company’s stock.
About Arteris
Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.
Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.
Read More
- Five stocks we like better than Arteris
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.
